Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Stryker logoStryker SYK

Stryker announced on December 4, 2025 that Spencer Stiles, who currently serves as Group President, Orthopaedics, has been appointed President and Chief Operating Officer, effective January 1, 2026.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Stryker announced on December 4, 2025 that Spencer Stiles, who currently serves as Group President, Orthopaedics, has been appointed President and Chief Operating Officer, effective January 1, 2026.

  2. The company said Dylan Crotty, who currently serves as President, Instruments, has been promoted to succeed Stiles as Group President, Orthopaedics effective January 1, 2026.

  3. Stryker said Stiles's annualized base salary will increase to $1,000,000 effective January 1, 2026, and his bonus target will be 100% of his annual base salary. The company said a recommendation will be made to the Compensation and Human Capital Committee to approve awards under the long-term incentive plan in February 2026 with an aggregate target value of approximately $6,000,000, comprised of 40% stock options and 60% performance stock units.

  4. Stryker said Crotty's annualized base salary will increase to $700,000 effective January 1, 2026, and his bonus target will be 85% of his annual base salary. The company said a recommendation will be made to the Compensation and Human Capital Committee to approve awards under the long-term incentive plan in February 2026 with an aggregate target value of approximately $3,000,000, comprised of 40% stock options and 60% performance stock units.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Spencer Stiles appointed President and Chief Operating Officer

Stryker announced on December 4, 2025 that Spencer Stiles, who currently serves as Group President, Orthopaedics, has been appointed President and Chief Operating Officer, effective January 1, 2026.

Source · Based on the filing body and exhibits

Dylan Crotty promoted to Group President, Orthopaedics

The company said Dylan Crotty, who currently serves as President, Instruments, has been promoted to succeed Stiles as Group President, Orthopaedics effective January 1, 2026.

Source · Based on the filing body and exhibits

Stiles compensation: annual base salary $1,000,000, long-term incentive approximately $6,000,000

Stryker said Stiles's annualized base salary will increase to $1,000,000 effective January 1, 2026, and his bonus target will be 100% of his annual base salary. The company said a recommendation will be made to the Compensation and Human Capital Committee to approve awards under the long-term incentive plan in February 2026 with an aggregate target value of approximately $6,000,000, comprised of 40% stock options and 60% performance stock units.

Source · Based on the filing body and exhibits

Crotty compensation: annual base salary $700,000, long-term incentive approximately $3,000,000

Stryker said Crotty's annualized base salary will increase to $700,000 effective January 1, 2026, and his bonus target will be 85% of his annual base salary. The company said a recommendation will be made to the Compensation and Human Capital Committee to approve awards under the long-term incentive plan in February 2026 with an aggregate target value of approximately $3,000,000, comprised of 40% stock options and 60% performance stock units.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.